Christopher Thomas Giordano - Jul 14, 2021 Form 3 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
CEO, Director
Signature
/s/ Chris Giordano
Stock symbol
TENX
Transactions as of
Jul 14, 2021
Transactions value $
$0
Form type
3
Date filed
7/15/2021, 04:33 PM
Next filing
Jun 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TENX Stock Option (right to buy) Jul 14, 2021 Common stock 250K $1.97 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable as follows: options with respect to 62,500 underlying shares of Common Stock vest and become exercisable on each of July 6, 2022, July 6, 2023, July 6, 2024, and July 6, 2025.
F2 In addition to this grant of stock options with respect to 250,000 shares of Common Stock, an additional management stock option with respect to 100,000 shares of Common Stock was made to the Reporting Person on July 6, 2021, vesting in two tranches upon achievement of specified performance metrics.

Remarks:

0 non-derivative securities beneficially owned.